1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Degenerative Spondylolisthesis Global Clinical Trials Review, H1, 2014

Degenerative Spondylolisthesis Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Degenerative Spondylolisthesis Global Clinical Trials Review, H1, 2014" provides data on the Degenerative Spondylolisthesis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Degenerative Spondylolisthesis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Degenerative Spondylolisthesis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Degenerative Spondylolisthesis Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Degenerative Spondylolisthesis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Degenerative Spondylolisthesis to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Degenerative Spondylolisthesis 21
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Degenerative Spondylolisthesis Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Mesoblast Limited 28
Clinical Trial Overview of Mesoblast Limited 28
Zimmer Holdings, Inc. 29
Clinical Trial Overview of Zimmer Holdings, Inc. 29
Olympus Biotech Corporation 30
Clinical Trial Overview of Olympus Biotech Corporation 30
Northern Orthopaedic Division, Denmark 31
Clinical Trial Overview of Northern Orthopaedic Division, Denmark 31
Clinical Trial Overview of Top Institutes / Government 32
Walsh University 32
Clinical Trial Overview of Walsh University 32
Zahedan University of Medical Sciences 33
Clinical Trial Overview of Zahedan University of Medical Sciences 33
Jyvaskyla Central Hospital 34
Clinical Trial Overview of Jyvaskyla Central Hospital 34
University Children Hospital Homburg 35
Clinical Trial Overview of University Children Hospital Homburg 35
Mayo Clinic 36
Clinical Trial Overview of Mayo Clinic 36
University Medical Centre Ljubljana 37
Clinical Trial Overview of University Medical Centre Ljubljana 37
Dartmouth-Hitchcock Medical Center 38
Clinical Trial Overview of Dartmouth-Hitchcock Medical Center 38
University Hospital, Bordeaux 39
Clinical Trial Overview of University Hospital, Bordeaux 39
UMC Utrecht Holding BV 40
Clinical Trial Overview of UMC Utrecht Holding BV 40
Leiden University Medical Center 41
Clinical Trial Overview of Leiden University Medical Center 41
Five Key Clinical Profiles 42
Appendix 68
Abbreviations 68
Definitions 68
Research Methodology 69
Secondary Research 69
About GlobalData 70
Contact Us 70
Disclaimer 70
Source 70

List of Tables
Degenerative Spondylolisthesis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Degenerative Spondylolisthesis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Degenerative Spondylolisthesis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Degenerative Spondylolisthesis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Degenerative Spondylolisthesis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Degenerative Spondylolisthesis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Degenerative Spondylolisthesis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Degenerative Spondylolisthesis to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Degenerative Spondylolisthesis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Degenerative Spondylolisthesis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Degenerative Spondylolisthesis Therapeutics, Global, Clinical Trials by Phase, 2014* 17
Degenerative Spondylolisthesis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 18
Degenerative Spondylolisthesis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Degenerative Spondylolisthesis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Degenerative Spondylolisthesis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 21
Degenerative Spondylolisthesis Therapeutics, Global, Terminated Clinical Trials, 2014* 22
Degenerative Spondylolisthesis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Degenerative Spondylolisthesis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Degenerative Spondylolisthesis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Degenerative Spondylolisthesis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Degenerative Spondylolisthesis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mesoblast Limited, 2014* 28
Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zimmer Holdings, Inc., 2014* 29
Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Olympus Biotech Corporation, 2014* 30
Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Northern Orthopaedic Division, Denmark, 2014* 31
Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Walsh University, 2014* 32
Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zahedan University of Medical Sciences, 2014* 33
Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Jyvaskyla Central Hospital, 2014* 34
Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Children Hospital Homburg, 2014* 35
Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014* 36
Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Centre Ljubljana, 2014* 37
Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dartmouth-Hitchcock Medical Center, 2014* 38
Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bordeaux, 2014* 39
Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2014* 40
Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2014* 41

List of Figures
Degenerative Spondylolisthesis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Degenerative Spondylolisthesis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Degenerative Spondylolisthesis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Degenerative Spondylolisthesis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Degenerative Spondylolisthesis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Degenerative Spondylolisthesis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Degenerative Spondylolisthesis to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Degenerative Spondylolisthesis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Degenerative Spondylolisthesis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Degenerative Spondylolisthesis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 17
Degenerative Spondylolisthesis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 18
Degenerative Spondylolisthesis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Degenerative Spondylolisthesis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Degenerative Spondylolisthesis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Degenerative Spondylolisthesis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Degenerative Spondylolisthesis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
GlobalData Methodology 69

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.